Thrombophilia Screening After Severe IUGR

NCT05551078 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-09-22

No results posted yet for this study

Summary

This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.

Conditions

  • IUGR
  • Thrombophilia
  • Pregnancy Complications

Interventions

BIOLOGICAL

thrombophilia screening

In the IUGR group systematic thrombophilia screening had already been performed.

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2022-10-31
Completion
2023-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05551078 on ClinicalTrials.gov